Inventor
KALTENBACH III ROBERT F
US20 patents
⚠️ This page may combine multiple inventors who share the name “KALTENBACH III ROBERT F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
15 patentsUS10662172B2May 26, 2020
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO30 citations94
US10576062B2Mar 3, 2020
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO18 citations93
US10071078B2Sep 11, 2018
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO21 citations93
US11447475B2Sep 20, 2022
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO3 citations73
US11180488B2Nov 23, 2021
Isoxazole o-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO4 citations73
US11007180B2May 18, 2021
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO3 citations72
US12384768B2Aug 12, 2025
Isoxazole carboxylic acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations62
US12195444B2Jan 14, 2025
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations62
US11697646B2Jul 11, 2023
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations62
US11267800B2Mar 8, 2022
Cyclohexyl acid triazole azines as LPA antagonists
BRISTOL MYERS SQUIBB CO2 citations62
US11008300B2May 18, 2021
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations62
USRE49352EJan 3, 2023
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations60
US12466804B2Nov 11, 2025
Cyclobutyl carboxylic acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations52
US12435057B2Oct 7, 2025
Triazole carboxylic acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations52
US12209072B2Jan 28, 2025
Cyclopentyl acids as LPA antagonists
BRISTOL MYERS SQUIBB CO0 citations52
DU PONT MERCK PHARMA
4 patentsUS5376664ADec 27, 1994
Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents
DU PONT MERCK PHARMA11 citations73
US5585382ADec 17, 1996
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
DU PONT MERCK PHARMA7 citations71
US5416089AMay 16, 1995
Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
DU PONT MERCK PHARMA12 citations71
US5559252ASep 24, 1996
Process for the preparation of diamine intermediates useful in the synthesis of HIV protease inhibitors
DU PONT MERCK PHARMA4 citations62